Gene therapy of the rheumatic diseases: 1998 to 2008.
Gene therapy of the rheumatic diseases: 1998 to 2008.
复制标题
DOI:
10.1186/ar2563
复制
发表时间:
2009
影响因子:
4.9
通讯作者:
Robbins PD
中科院分区:
文献类型:
--
作者:
Evans CH;Ghivizzani SC;Robbins PD
During the decade since the launch of Arthritis Research, the application of gene therapy to the rheumatic diseases has experienced the same vicissitudes as the field of gene therapy as a whole. There have been conceptual and technological advances and an increase in the number of clinical trials. However, funding has been unreliable and a small number of high-profile deaths in human trials, including one in an arthritis gene therapy trial, have provided ammunition to skeptics. Nevertheless, steady progress has been made in a number of applications, including rheumatoid arthritis and osteoarthritis, Sjögren syndrome, and lupus. Clinical trials in rheumatoid arthritis have progressed to phase II and have provided the first glimpses of possible efficacy. Two phase I protocols for osteoarthritis are under way. Proof of principle has been demonstrated in animal models of Sjögren syndrome and lupus. For certain indications, the major technological barriers to the development of genetic therapies seem to have been largely overcome. The translational research necessary to turn these advances into effective genetic medicines requires sustained funding and continuity of effort.
登录
查看更多内容
DOI:
10.1099/vir.0.82603-0
发表时间:
2007-06
期刊:
The Journal of general virology
影响因子:
--
作者:
Adriaansen J;Fallaux FJ;de Cortie CJ;Vervoordeldonk MJ;Tak PP
通讯作者:
Tak PP
影响因子:
46.9
作者:
Dalum, I;Butler, DM;Mouritsen, S
通讯作者:
Mouritsen, S
影响因子:
5.1
作者:
Fellowes, R;Etheridge, CJ;Woo, P
通讯作者:
Woo, P
影响因子:
6
作者:
Fernandes, J;Tardif, G;Pelletier, JP
通讯作者:
Pelletier, JP
影响因子:
4.2
作者:
Apparailly, F;Millet, V;Jorgensen, C
通讯作者:
Jorgensen, C